Head to Head Comparison: Pheton (NASDAQ:PTHL) & Establishment Labs (NASDAQ:ESTA)

Establishment Labs (NASDAQ:ESTA) and Pheton (NASDAQ:PTHL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Institutional and Insider Ownership

72.9% of Establishment Labs shares are owned by institutional investors. 11.4% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Risk and Volatility

Establishment Labs has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Pheton has a beta of 5.4, meaning that its share price is 440% more volatile than the S&P 500.

Valuation & Earnings

This table compares Establishment Labs and Pheton”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08 million	7.68	-$51.06 million	($1.74)	-31.79
Pheton	$305,215.00	8.49	-$660,000.00	N/A	N/A

Pheton has lower revenue, but higher earnings than Establishment Labs.

Profitability

This table compares Establishment Labs and Pheton’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-24.19%	-201.79%	-15.03%
Pheton	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for Establishment Labs and Pheton, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1	1	6	0	2.63
Pheton	1	0	0	0	1.00

Establishment Labs currently has a consensus price target of $86.86, indicating a potential upside of 57.04%. Given Establishment Labs’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Establishment Labs is more favorable than Pheton.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.